Umbilical Cord Tissue Stem Cells and Biomaterials(Vitti Lab)

N/A

Report date: 2025/02/28 10:17:12

Base Information

Drug NameUmbilical Cord Tissue Stem Cells and Biomaterials(Vitti Lab)
Drug Alias NameVL-P22
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVitti Labs LLC
China Registration ClassN/A

Develop Information

Active CompaniesVitti Labs LLC
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A